To directly assess whether HCC tumors mount a response to ferroptotic susceptibility, we stained a panel of HCC tumors with GPX4 (a key mediator of ferroptotic responses through its ability to reduce lipid hydroperoxides) and observed strong positivity of GPX4 in tumors but not in normal tissues (fig. The gene discussed is GPX4; the disease is hepatocellular carcinoma.